ITMCTR2200005794尚未招募4 期
Clinical Observation of Shengui Capsule Intervention in Heart Failure with Preserved Ejection Fraction
Dongzhimen Hospital, Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 40 至 80(—)
- 性别
- All
入选标准
- •? Patients with heart failure with preserved ejection fraction who meet the diagnostic criteria and have symptoms who need diuretics and whose cardiac function class (NYHA class) is II to IV;
- •?Meet the 2019ESC diagnostic criteria for chronic coronary syndrome
- •? The cause of heart failure in patients with preserved ejection fraction is caused by coronary heart disease;
- •?Traditional Chinese medicine for heart failure patients with heart-yang insufficiency, qi deficiency and blood stasis;
- •? Those who received at least 2 weeks of standardized western medicine treatment and reached the optimal dose;
- •? Those who have not used traditional Chinese medicine/proprietary Chinese medicine for the treatment of heart failure within 2 weeks before enrollment;
- •?Age between 40-80 years old;
- •? Those who are in good spirits and able to communicate verbally and in writing;
- •? The HFpEF patients who signed the informed consent form voluntarily participated in this study.
排除标准
- •? Under stable conditions, any previous echocardiographic measurement of LVEF = 50%;
- •? Acute decompensated heart failure within 30 days prior to screening, or acute coronary syndrome (including myocardial infarction), cardiac surgery, other major cardiovascular surgery, or emergency percutaneous coronary intervention within 3 months prior to screening interventional therapy;
- •? At the time of screening, walking distance was mainly limited by non-cardiac disease;
- •? History of dilated cardiomyopathy, including perinatal cardiomyopathy, chemotherapy-induced cardiomyopathy or viral myocarditis;
- •? History of hypertension and poor blood pressure control (systolic blood pressure = 160 mmHg, or diastolic blood pressure = 100 mmHg);
- •? Patients with glycated hemoglobin>7.5% did not receive diabetes treatment;
- •? Patients with serious primary diseases such as lung, brain, liver, kidney, hematopoietic system, mental illness, and severe neurosis;
- •? Patients with Yin deficiency and Yang Sheng with symptoms such as burning skin, five upset hearts, shortness of breath, and constipation;
- •?Allergic constitution or allergic to known components of the test drug.
研究者
相似试验
尚未招募
1 期
Clinical study of Shenyuan Yiqi Huoxue Capsule on cardiopulmonary motor function and quality of life in patients with Ischemic CardiomyopathyIschemic cardiomyopathyITMCTR2200006813Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University
招募中
4 期
Clinical Tiral of Suhuang Zhike Capsule in Treating Cough after Thoracoscopic Pneumonectomy for Early Non-small Cell Lung CancerITMCTR2100005223Peking University people's Hospital
尚未招募
4 期
Clinical trial of Zhen Shu Tiu Zhi Capsule in treating diabetic damp heat syndrome and study on biological basis of damp heat syndrome of glycolipid metabolic diseasesDiabetesITMCTR2200005519Dongzhimen Hospital, Beijing University of Chinese Medicine
招募中
1 期
Clinical study on the intervention of Shen Weisheng's traditional Chinese Medicine Qingre Lianyin Decoction on the side effects of radiotherapy on head and neck tumorsITMCTR2100004593Jiangyin People's Hospital
尚未招募
4 期
Clinical study of Xuefu Zhuyu Capsule in the treatment of acute chest pain after thoracoscopic surgery for early non-small cell lung cancerSCLCITMCTR2200005757Peking University People's Hospital
